View Older Stories View More Recent Stories

May 8, 2025 04:05PM Cytek Biosciences Reports First Quarter 2025 Financial Results
Apr 29, 2025 05:00PM Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
Apr 24, 2025 04:05PM Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025
Mar 18, 2025 05:14PM Cytek® Biosciences (CTKB) announces Cytek Muse Micro system
Mar 18, 2025 05:00PM Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
Feb 27, 2025 04:05PM Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
Feb 13, 2025 04:05PM Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Feb 5, 2025 04:05PM Cytek Biosciences to Participate in Upcoming Investor Conferences
Jan 15, 2025 08:04AM Cytek® Biosciences (CTKB) Reports Prelim FY24 Results
Jan 15, 2025 08:00AM Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results
Jan 2, 2025 08:00AM Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference
Dec 30, 2024 08:03AM Cytek® Biosciences (CTKB) Announces $50M Share Buyback
Dec 30, 2024 08:00AM Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
Nov 20, 2024 04:05PM Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference
Nov 19, 2024 05:00PM Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
Nov 7, 2024 05:00PM Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
Nov 5, 2024 04:05PM Cytek Biosciences Reports Third Quarter 2024 Financial Results
Oct 30, 2024 04:05PM Cytek Biosciences to Participate in Upcoming Investor Conferences
Oct 29, 2024 04:05PM Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024
Sep 18, 2024 05:00PM Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
Sep 12, 2024 03:20PM Cytek Announces Resignation of Chief Operating Officer Chris Williams
Aug 21, 2024 05:00PM Cytek® Biosciences (CTKB) Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
Aug 21, 2024 05:00PM Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
Aug 8, 2024 04:05PM Cytek Biosciences to Participate in Upcoming Investor Conferences
Aug 6, 2024 04:05PM Cytek Biosciences Reports Second Quarter 2024 Financial Results
Jul 30, 2024 05:00PM Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
Jul 30, 2024 04:05PM Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024
Jun 6, 2024 08:00AM Cytek® Biosciences (CTKB) Announces $50 Million Stock Repurchase Program
Jun 6, 2024 08:00AM Cytek Biosciences Announces $50 Million Stock Repurchase Program
May 30, 2024 04:05PM Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
May 28, 2024 05:30PM 1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
May 20, 2024 05:30PM Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
May 8, 2024 04:05PM Cytek Biosciences Reports First Quarter 2024 Financial Results
Apr 30, 2024 05:30PM Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
Apr 29, 2024 09:00AM Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024
Mar 19, 2024 08:03AM Cytek® Biosciences (CTKB) Names William McCombe Chief Financial Officer, 2024 Outlook Reaffirmed
Mar 19, 2024 08:00AM Cytek® Biosciences Names William McCombe Chief Financial Officer
Mar 7, 2024 05:30PM Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
Feb 28, 2024 05:05PM Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
Feb 7, 2024 04:10PM Cytek Biosciences to Participate in Upcoming Investor Conferences
Feb 7, 2024 04:05PM Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Jan 17, 2024 05:30PM Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
Jan 8, 2024 09:07AM Cytek® Biosciences (CTKB) Announces Preliminary Full Year 2023 Revenue Results
Jan 8, 2024 09:00AM Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
Dec 28, 2023 04:05PM Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
Dec 21, 2023 09:00AM Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
Nov 14, 2023 04:05PM Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference
Nov 8, 2023 09:00AM Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’
Nov 7, 2023 04:05PM Cytek Biosciences Reports Third Quarter 2023 Financial Results
Oct 19, 2023 04:05PM Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023
View More Recent Stories View Older Stories